Navigation Links
Inadequate epilepsy treatment

The diagnosis and treatment of epilepsy is often handled in a casual “insouciant” manner, with up to 20 per cent of UK epilepsy patients not receiving appropriate drugs, researchers say. Around 30,000 people are diagnosed with epilepsy each year, and of these, about one-third can be expected to continue on long-term medication. But researchers from the Institute of Neurology at University College London have found that some epilepsy treatment regimes are outmoded, inappropriate or given too late to be of maximum benefit to patients. //

The team monitored the treatment patterns of 564 epilepsy patients for up to 14 years after diagnosis. Their work forms part of the United Kingdom General Practice Study of Epilepsy – a long-term population-based study of the condition.

The researchers found that less than half of epilepsy patients with partial seizures and less than a third with generalised seizures were treated with recommended treatments. Only 11 per cent of patients received the latest medication and 7 per cent had been kept on the same drug despite failing to achieve remission after two years.

UK doctors are reluctant to prescribe drugs to patients who have had one seizure, the researchers say. About 15 per cent of the patients monitored received drugs after their first epileptic seizure, although high rates of recurring seizures meant that more than 75 per cent of the group received treatment at some point.

'"/>




Page: 1

Related medicine news :

1. Inadequate Drug Treatment For Youth
2. Inadequate proof to justify routine prostate screen
3. Sterilization Of Dental Instruments Is Inadequate, Says Study
4. Inadequate labeling in sandwiches sold at UK supermarkets
5. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
6. Training in Australias Medical Schools Inadequate
7. Inadequate Mental Health Fundings, Experts Warn
8. AMA Warns Of Inadequately Trained Doctors Due To Lack of Resources
9. Treatment For ADHD In Kids Inadequate
10. Healthcare Inadequate at Yarl’s Wood Immigration Cente
11. Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... Castle Dermatology Institute is now ... to restore a more youthful appearance to the face. Dr. Peyman Ghasri and Dr. ... a variety of other treatments, to rejuvenate and renew the facial appearance. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... They are musicians and librarians, fashion designers and ... fathers, from New England and around the nation. What do they have in common? ... in a beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff ... located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, ... treatment for a brain tumor. , Jason Bauer and his family are longtime ...
(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, ... is painful for her. "This is why the co-inventor and I have designed a ... They then created a prototype of the patent-pending AV-AIR, a device that serves as ...
(Date:12/7/2016)... ... 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s best ... Dermatitis Associated with Borrelia Infection” reveals that a condition similar to ... prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is an ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... YORK , Dec. 7, 2016  Urinary ... incontinence, urinary retention and other urological disorders. Urinary ... and external (condom) catheter. Indwelling or Foley catheter ... ends. This type of catheter is inserted into ... the bladder. A tiny balloon attachment at one ...
(Date:12/7/2016)... , Dec. 7, 2016 A new investigational drug ... human clinical trials in search of the world,s first treatment ... publication of research findings today in the journal ... will be a watershed moment for millions of people living ... director of Van Andel Research Institute,s Center ...
(Date:12/7/2016)... Dec. 7, 2016  Northwest Biotherapeutics (Nasdaq: ... a biotechnology company developing DCVax® personalized immune therapies ... Nasdaq Staff has not accepted the Company,s plan ... previously reported, and the Company has notified Nasdaq ... common stock from listing on Nasdaq.  Upon withdrawal ...
Breaking Medicine Technology: